YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 05, 16:00
3495.85
-58.45 (-1.64%)
VOLUME 20,083
LIVE
NSE
Mar 05, 15:58
3496.90
-56.55 (-1.59%)
VOLUME 390,702
News on Divis Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y

10.57 am | 05 Mar 2021 |  Source: Moneycontrol.com

NULL...

Crude's rise, rupee's fall looming risks for markets but these 8 stocks may reap benefit

2.00 pm | 03 Mar 2021 |  Source: Moneycontrol.com

The recent rise in crude oil prices has kept the Indian currency under pressure. The rupee is now above the 73 mark per US dollar....

Buy Divi’s Laboratories; target of Rs 4440: ICICI Direct

3.30 pm | 10 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 4440 in its research report dated F...

Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y

10.00 am | 09 Feb 2021 |  Source: Moneycontrol.com

NULL...

Divis Labs Standalone December 2020 Net Sales at Rs 1,656.48 crore, up 19.13% Y-o-Y

9.22 am | 09 Feb 2021 |  Source: Moneycontrol.com

NULL...

Divi’s Labs: All set to reap investments

9.54 am | 08 Feb 2021 |  Source: Moneycontrol.com

Since the macro context is fragile, eventually liquidity will continue to chase cash rich and cash flow positive businesses such as Divi’s Labs...

Buy Divi's Laboratories; target of Rs 4425: ICICI Direct

12.42 pm | 30 Dec 2020 |  Source: Moneycontrol.com

ICICI Securities is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4425 in its research report dated...

Buy Divis Laboratories: target of Rs 4175: Sharekhan

2.02 pm | 07 Dec 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 4175 in its research report dated December 04...

Buy Divis Laboratories: target of Rs 3800: Sharekhan

11.30 am | 11 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06...

Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal

12.12 pm | 10 Nov 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3900 in its research report dated Nove...

Divi’s Labs: Improved growth visibility for custom synthesis, but valuation rich

9.42 am | 10 Nov 2020 |  Source: Moneycontrol.com

Divi's Labs result re-emphasise the fact that the global trend of de-risking supply chains away from China is adding to order enquires and product...

Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market

1.38 pm | 09 Nov 2020 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Divi's Laboratories with a target price of Rs 3515 in its research report dated November 08,...

Buy Divi's Laboratories; target of Rs 4205: ICICI Direct

11.52 am | 09 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4205 in its research report dated Nov...

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.